CLOVIS ONCOLOGY INC - COM (CLVSQ)

CUSIP: 189464100

Q4 2022 13F Holders as of 31 Dec 2022

Type / Class
Equity / COM
Total 13F shares
399,191
Share change
-35,197,990
Total reported value
$499,094
Price per share
$0.05
Number of holders
11
Value change
-$41,909,415
Number of buys
2
Number of sells
80

Quarterly Holders Quick Answers

What is CUSIP 189464100?
CUSIP 189464100 identifies CLVSQ - CLOVIS ONCOLOGY INC - COM in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of CLOVIS ONCOLOGY INC - COM (CLVSQ) as of Q4 2022

As of 31 Dec 2022, CLOVIS ONCOLOGY INC - COM (CLVSQ) was held by 11 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 399,191 shares. The largest 10 holders included MACQUARIE GROUP LTD, S&T Bank/PA, WEDBUSH SECURITIES INC, MAI Capital Management, Future Financial Wealth Managment LLC, Newbridge Financial Services Group, Inc., Qube Research & Technologies Ltd, IFP Advisors, Inc, Coppell Advisory Solutions LLC, and Coppell Advisory Solutions Corp.. This page lists 11 institutional shareholders reporting positions in this security for the Q4 2022 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.